Christopher Trummer is a seasoned biotech investor, founder, and mentor, currently serving as Co-Founder of Venga Ventures since July 2024, where the focus is on enabling future biotech ecosystems. As a founder of the Fall '22 Med Cohort at StartX, Christopher contributes to an accelerator that has supported over 135 medical companies, generating more than $920 million in funding. Additionally, Christopher is a board member of BIOTECH AUSTRIA, working to foster an innovative biotechnology sector in Austria. Previously, Christopher founded and led Celeris Therapeutics, pioneering AI-driven degrader design and securing approximately 20 million EUR in capital. With extensive experience in business development within pharma and biotechnology, along with a strong education in biotechnology and business informatics, Christopher Trummer is a significant figure in advancing the biotech industry.
This person is not in the org chart
This person is not in any offices